课题基金 / 基金详情

Development of new methods in diagnosis and treatment of tumors by the targeting of chimeric protein

Development of new methods in diagnosis and treatment of tumors by the targeting of chimeric protein
开发靶向嵌合蛋白的肿瘤诊断和治疗新方法
批准号:
08557018
负责人:
MORI Shigeo
金额:
$9.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1998

项目摘要

项目成果

MORI Shigeo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The chimeric gene is a unique non-natural gene made by the fusion of two different genes, causing production of a novel protein with the head and tail parts made of two different genes. Some of such chimeric protein cause specific diseases like soft part sarcoma and malignant lymphomas. This study was aimed (1)to identify new pathogenetic chimeric genes/proteins, (2)Biological function of chimeric proteins, (3)Application of chimeric proteins in the diagnosis and treatment of human diseases.(1) Identification of new pathogenetic chimeric genes/proteins :Over 20 chimeric genes were identified from human malignant lymphomas a part of which was derived from BCL6 gene. Some of them were found to be new genes. Also, a new type of TLS/FUS-CHOP chimeric gene was identified from human liposarcoma tissues.(2) Biological function of chimeric proteins :A part of the biological functions of NPM/ALK chimeric protein was clarified. Also, the biological function of BCL6 gene product was partly clarified.(3) Application of chimeric proteins in the diagnosis and treatment of human diseases :With the introduction of newly developed antibody to NPM/ALK chimeric protein, we invested an easy and conclusive diagnostic method for the NPM/ALK chimera-related human diseases. Also, we could transfer over 20 cases of human malignant lymphomas bearing different types of chimera genes. This cell line is now under study for the targeting of these genes in immunotherapy.
期刊论文(47)
专著(0)
科研奖励(0)
会议论文
Yee HT: "Molecular characterization of the t (2 ; 5) (p23 ; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease." Blood. 87. 1081-88 (1996)
Yee HT:“间变性大细胞淋巴瘤 (Ki-1) 和霍奇金病中 t (2 ; 5) (p23 ; q35) 易位的分子特征。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Aizawa S: "Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation." J Biol Chem. 272(4). 2042-5 (1997)
Aizawa S:“肿瘤坏死因子受体相关因子 (TRAF) 5 和 TRAF2 参与 CD30 介导的 NFkappaB 激活。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Aizawa S: "Cloning and characterization of a cDNA for rat CD30 homolog and chromosomal assignment of the genomic gene." Gene. 182(1-2). 155-62 (1996)
Aizawa S:“大鼠 CD30 同源物 cDNA 的克隆和表征以及基因组基因的染色体分配。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fujimoto J.Shiota M.Iwahara T.Seki N.Satoh H.Mori S.Yamamoto T: "Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t (2 ; 5)." Proc Natl Acad Sci USA. 93 (9). 41
Fujimoto J.Shiota M.Iwahara T.Seki N.Satoh H.Mori S.Yamamoto T:“p80 转化活性的表征,p80 是具有染色体易位的 Ki-1 淋巴瘤细胞系中的一种过度磷酸化蛋白 t (2 ; 5)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
43
    Exploration of new magnetic materials by controlling nanostructures
    • 批准号:
      23656404
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2011
    • 负责人:
      MORI Shigeo
    • 依托单位:
    Magnetoelecric relaxors
    • 批准号:
      20340078
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2008
    • 负责人:
      MORI Shigeo
    • 依托单位:
    Construction of Database on Iranian Worship and Belief and Applied Research of Theories of Persian Literature in Expanded Form
    • 批准号:
      19320050
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2007
    • 负责人:
      MORI Shigeo
    • 依托单位:
    Correlation Phenomena among electric, magnetic and mulitiple dipoles in ferroelectric oxides
    • 批准号:
      16340094
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.55万
    • 财政年份:
      2004
    • 负责人:
      MORI Shigeo
    • 依托单位:
    海外基金